Assessment of the combination of fenofibrate and sildenafil in alzheimer’s disease
Abstract
The purpose of the study was to evaluate the effectiveness of fenofibrate and sildenafil at various dosages in the treatment of Alzheimer’s disease. Sildenafil is an up-regulator of brain-derived neurotrophic factor (BDNF), whereas fenofibrate is a powerful PPAR-α activator. The typical medication was rivastigmine, while the inducer was AlCl3 . The tests of spatial working memory included the MWM, Y-Maze, and NOR. Moreover, the levels of Aβ, PPAR-α, BDNF, TNF-α, and IL-1β in the brain were measured using ELISA kits. During the probing session, the MWM displayed a decline in escape latency and rise in the target quadrant entry. The results of the Y-maze and the NOR demonstrated the emergence of spontaneous changes in the discrimination and recognition index scores. The therapy groups showed decline in the levels of TNF-α, IL-1β, and Aβ. The brain histology of the treated group showed moderate neurodegeneration. From this study, we can conclude that fenofibrate and sildenafil when used in combination could be a successful treatment for AD.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.